Israel wiped out Iranian leaders in attack inspired by Game of Thrones scene
Israeli Prime Minister Benjamin Netanyahu reportedly took on the spirit of Game of Thrones character Tywin Lannister when he used deception to plan the devastating attacks on Iran
Israel wiped out top Iranian nuclear scientists and military leaders in an attack said to have been inspired by a famous scene from HBO's Game of Thrones.
The operation, where bombs were coordinated to rain down on Tehran on June 13, was referred to as the "Red Wedding" by Israeli military officials. The scene is one of the most famous in modern TV history, with key figures of House Stark being killed on the orders of House Lannister during a wedding, decisively bringing an end to the North's rebellion against the crown.
Israel's generals watched from a bunker as Israel carried out he devastating attack above ground. When the dust settled, some 30 military officials, including the IRGG chief as well as the chief of staff of the country's Armed Forces were killed in the strike alongside nine of Iran's top scientists who endeavoured to improve its enrichment programme.
The US then carried out its own strikes on three nuclear sites, using so-called "bunker busters" before claiming the country's nuclear capabilities had been "totally obliterated." At least 1,054 people in Iran as well as 318 military personnel have died following the attacks.
Israel's Prime Minister Benjamin Netanyahu took on the spirit of GOT character Tywin Lannister by carrying out a campaign of deception, tricking his own son and wife and drawing the US into the conflict. Mr Netanyahu announced he would take a short break to celebrate Avner's wedding on June 16 but he was in fact plotting to delay the wedding - something he had not told his family, the Wall Street Journal reported.
Mr Netanyahu's media team then leaked claims of a rift between him and the president with Mr Trump going on to urge Israel not to strike. By this time, Mr Trump had been briefed that Israel would carry out a strike.
The plan was then carried out with Iran's military being hit simultaneously, which became to be known as the Red Wedding. Israeli officials feared the plan was in jeopardy when Iran learned about the strike, but their leaders ended up gathering together in one place.
Among those killed include Mohammad Bagheri, the commander in chief of Iran's military, General Amir Ali Hajizadeh, the leader of the airspace unit of the Revolutionary Guards. Top scientists were also killed after bombs exploded at the homes of nine researchers.
Major General Oded Basiuk, the head of Israel's Operations Directorate who planned the attack, said i was impossible to know if it would be successful. MailOnline reported he said: "When we started to plan this thing in detail, it was very difficult to know that this would work."
A leaked US intelligence report cast doubt the American strikes had "obliterated" Iran's nuclear capabilities and halted its plan to obtain weapons of mass destruction by years. But the Trump administration has hit out against the report and claimed the mission was among the most decisive in history.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
6 minutes ago
- Glasgow Times
Talks on nuclear programme complicated by US strikes, Iran says
Iranian foreign minister Abbas Araghchi told state television that the attacks had caused 'serious damage'. The US was one of the parties to the 2015 nuclear deal in which Iran agreed to limits on its uranium enrichment programme in exchange for sanctions relief and other benefits. The deal unravelled after President Donald Trump pulled the US out unilaterally during his first term. Mr Trump has suggested he is interested in new talks with Iran and said the two sides would meet next week. Mr Araghchi left open the possibility that his country would again enter talks on its nuclear programme, but suggested it would not be any time soon. 'No agreement has been made for resuming the negotiations,' he said. 'No time has been set, no promise has been made and we haven't even talked about restarting the talks.' The American decision to intervene militarily 'made it more complicated and more difficult' for talks, Mr Araghchi said. Israel attacked Iran on June 13, targeting its nuclear sites, defence systems, high-ranking military officials and atomic scientists. In 12 days of strikes, Israel said it killed some 30 Iranian commanders and hit eight nuclear-related facilities and more than 720 military infrastructure sites. More than 1,000 people were killed, including at least 417 civilians, according to the Washington-based Human Rights Activists group. Iran fired more than 550 ballistic missiles at Israel, most of which were intercepted but those that got through caused damage in many areas and killed 28 people. The US stepped in on Sunday to hit Iran's three most important sites with a wave of cruise missiles and bunker-buster bombs dropped by B-2 bombers, designed to penetrate deep into the ground to damage the heavily-fortified targets. Iran, in retaliation, fired missiles at a US base in Qatar on Monday but caused no known casualties. Mr Trump said the American attacks 'completely and fully obliterated' Iran's nuclear programme, though Iran's Supreme Leader Ayatollah Ali Khamenei on Thursday accused the US president of exaggerating the damage, saying the strikes did not 'achieve anything significant'. There has been speculation that Iran moved much of its highly-enriched uranium before the strikes, something it told UN nuclear watchdog the International Atomic Energy Agency (IAEA) that it planned to do. Even if that turns out to be true, IAEA director Rafael Grossi told Radio France International that the damage done to the Fordo site, which was built into a mountain, 'is very, very, very considerable'. Among other things, he said, centrifuges are 'quite precise machines' and it's 'not possible' that the concussion from multiple 30,000-pound bombs would not have caused 'important physical damage'. 'These centrifuges are no longer operational,' he said. Mr Araghchi himself acknowledged that 'the level of damage is high, and it's serious damage'. He added that Iran had not yet decided upon whether to allow IAEA inspectors in to assess the damage, but that they would be kept out 'for the time being'.
Glasgow Times
6 minutes ago
- Glasgow Times
US and China sign trade agreement, Donald Trump says
Commerce Secretary Howard Lutnick told Bloomberg TV that the deal was signed earlier this week. Neither Mr Lutnick nor Mr Trump provided any details about the agreement. 'We just signed with China the other day,' Mr Trump said late on Thursday. Mr Lutnick said the deal was 'signed and sealed' two days earlier. It follows initial talks in Geneva in early May that led both sides to postpone massive tariff hikes that were threatening to freeze much trade between the two countries. Later talks in London set a framework for negotiations and the deal mentioned by Mr Trump appeared to formalise that agreement. Mr Lutnick said: 'The president likes to close these deals himself. He's the dealmaker. We're going to have deal after deal.' China has not confirmed any new agreements, but it announced earlier this week that it was speeding up approvals of exports of rare earths, materials used in high-tech products such as electric vehicles. Beijing's limits on exports of rare earths have been a key point of contention. The Chinese Commerce Ministry said on Thursday that Beijing was accelerating a review of export licence applications for rare earths and had approved 'a certain number of compliant applications'.
The Guardian
16 minutes ago
- The Guardian
EU retaliating to Trump drug tariffs would be ‘a bad idea', says industry
The European pharmaceutical industry has urged Brussels not to retaliate if Donald Trump brings in threatened tariffs on imported drugs, amid fears he could impose the levies as early as next week. The US president said last week that the sector-specific tariffs were coming 'very soon' and there is concern in Brussels that he could impose them imminently to give him further leverage ahead of his self-imposed 9 July deadline for trade deals with the EU and about 60 other countries. However, at a briefing in the Belgium capital on Thursday, the president of the European Federation of Pharmaceutical Industries and Associations said it would hurt everyone if the EU hit back with its own import duties. 'We're shipping a lot of exports out of the US into Europe,' Stefan Oelrich said. 'If we add tariffs to that, it's going to be negative for both sides. If we reciprocate on tariffs, it's just a bad idea. It's a bad concept.' The dynamics of the EU's negotiations with the US remain finely balanced. France and Germany both back a 'quick' UK-style deal and many member states, particularly the Baltic nations, are keen to build on warmer relations with Trump after his 'big win' at the Nato summit over increased defence spending, as they want to keep the president supporting Ukraine. With the clock ticking, speculation is mounting that the EU will do a thin deal on auto and steel – similar to the bilateral agreement brokered by Keir Starmer in May, which comes into force on Monday – but with no optimism in the pharma industry that it will be included. Oelrich said: 'There's no specific ask [of the US] other than … to the degree possible to limit trade barriers to zero, which would be the ideal case for us and/or something similar to zero. 'Tariffs will increase the cost of medicine and care. Tariffs will also create, ultimately, higher costs to patients.' After EU leaders met on Thursday, the German chancellor, Friedrich Merz, urged the EU to do a 'quick and simple' trade deal rather than a 'slow and complicated' one. His French counterpart, Emmanuel Macron, said he wanted a quick and pragmatic agreement, but could not accept terms that were not balanced. Oelrich, who is a member of the board of management at German pharmaceutical company Bayer, also called for a series of reforms on financing, pricing and regulation of drugs, saying such changes could help to restore Europe's former lead in research and development of drugs. His call comes amid fears the that EU is losing out to the US and, increasingly, China, which outpaced Europe in 2023 as originator of new active substances, with 25 brought to the world market, compared to the EU's 17 and the US's 28. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion Oelrich said data showed that 'a quarter of drugs in the past 10 years approved by FDA' in the US had not made it to Europe because of non-tariff barriers, such as differing national regulations and pricing. 'Many of the biotech companies are not even bothering engaging in Europe. For them it makes no sense,' he said. Among the other non-tariff barriers he cited were practices in the industry known as 'clawbacks' whereby governments in large economies including France and the UK agree a specific budget for procurement of particular drugs. But any surplus used in hospitals and clinics is paid for by the pharma companies as a clawback. 'It's totally senseless. And that's happening in Europe, and that needs to stop. I could name you endless countries that actually are doing this in Europe,' he said. 'What happens too much in Europe is that the richest countries would like to align to the lowest prices in lower equity countries … this leads to a situation which is unsustainable.'
